Showing results (1-10 of 27) with videos related to
Sort By:
Pageof 3
Statistics in Medicine|January 31, 2020
Analysis of counts for cluster randomized trials: Negative controls and test-negative designsSuzanne M Dufault, Nicholas P JewellResearch Square|November 21, 2023
Estimands for clinical endpoints in Tuberculosis treatment randomized controlled trials: a retrospective application in a completed trialIsabelle R Weir, Suzanne M Dufault, Patrick Pj PhillipsStatistical Methods in Medical Research|June 20, 2025
Spatiotemporal effects on dengue incidence based on a large cluster randomized studyJerome Johnson, Xiangyu Yu, Suzanne M Dufault, et al.Trials|March 12, 2024
Estimands for clinical endpoints in tuberculosis treatment randomized controlled trials: a retrospective application in a completed trialIsabelle R Weir, Suzanne M Dufault, Patrick P J PhillipsTrials|September 24, 2025
Comparison of methods for identifying the optimal treatment duration in randomized trials for antibioticsSuzanne M Dufault, Brian H Aldana, Patrick P J PhillipsThe Annals of Applied Statistics|August 26, 2025
RANDOMIZATION INFERENCE FOR CLUSTER-RANDOMIZED TEST-NEGATIVE DESIGNS WITH APPLICATION TO DENGUE STUDIES: UNBIASED ESTIMATION, PARTIAL COMPLIANCE, AND STEPPED-WEDGE DESIGNBingkai Wang, Suzanne M Dufault, Dylan S Small, et al.Mayo Clinic Proceedings|November 10, 2020
Cancer and Cardiovascular Risk in Women With Hypertensive Disorders of Pregnancy Carrying a Common IGF1R VariantMark J Powell, Suzanne M Dufault, Erica P Gunderson, et al.Statistics in Medicine|December 1, 2023
A flexible multi-metric Bayesian framework for decision-making in Phase II multi-arm multi-stage studiesSuzanne M Dufault, Angela M Crook, Katie Rolfe, et al.The Annals of Pharmacotherapy|December 8, 2025
Association of Baseline Comorbidities With First-Year Adherence to GLP-1 Receptor Agonists in Patients With Diabetes or Obesity: A Retrospective Cohort StudyZiyang Mai, John Kornak, Suzanne M Dufault, et al.Contemporary Clinical Trials|July 11, 2025
Designing a response-over-continuous-intervention (ROCI) randomised trial: Implementation in the Phase 2C part (duration ranging) of the PARADIGM4TB trialTra My Pham, Angela M Crook, Katie Rolfe, et al.Pageof 3